Macrophage ROS production and polarization machinery

The macrophage ROS production and polarization machinery refers to the integrated network of enzymes, signaling pathways, and metabolic processes that determine the functional state of macrophages. Central to this machinery is the production of reactive oxygen species (ROS) by NADPH oxidase (specifically NOX2) and mitochondria, which serves both as a microbicidal tool and a critical signaling mediator for polarization into pro-inflammatory (M1) or anti-inflammatory (M2) phenotypes [1, 8]. M1 macrophages utilize high ROS levels to drive inflammatory responses via pathways like NF-κB and MAPK, while M2 macrophages typically exhibit lower ROS and rely on oxidative metabolism for tissue repair [3, 6]. Dysregulation of this machinery is a hallmark of various diseases, including chronic inflammation, cancer, and atherosclerosis, where an imbalance in M1/M2 populations contributes to pathogenesis [1, 5]. Therapeutic strategies aim to reprogram these cells using small molecules like dimethyl fumarate, MEK inhibitors, or targeted delivery systems to restore homeostatic balance [4, 9]. However, challenges remain regarding the specificity of these interventions and the risk of impairing essential immune defenses such as pathogen killing [8].

Other names

Macrophage polarization pathwayMacrophage redox signaling machineryM1/M2 polarization networkMacrophage ROS-polarization axis

Modulation of macrophage phenotype through the regulation of reactive oxygen species (ROS) levels and downstream signaling pathways (e.g., NF-κB, Nrf2, JAK/STAT) to shift polarization between pro-inflammatory (M1) and anti-inflammatory (M2) states.